Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes

NCT01313533 is registered in ClinicalTrials.gov with St. Luke's Hospital, Chesterfield, Missouri as lead sponsor.

NCT NCT01313533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01313533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes
Lead sponsor
St. Luke's Hospital, Chesterfield, Missouri
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
November 30, 2021
Enrollment
540 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis